WASHINGTON, Sept. 12, 2019 /PRNewswire/ -- Nine U.S. states had adult obesity rates above 35 percent in 2018, up from seven states at that level in 2017, an historic level of obesity in the U.S., according to the 16th annual State of Obesity: Better Policies for a Healthier America report released today by the Trust for America's Health (TFAH).

BASEL, Switzerland, Sept. 12, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, placebo-controlled, Phase 3 clin

GOTHENBURG, Sweden, Sept. 12, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that an abstract highlighting the study design of its ongoing pivotal/registration-based AGENT clinical study (ISO-CC-007) in metastatic colorectal cancer (mCRC) will be presented at the European Society for Medical Oncology

TEL AVIV, Israel, Sept. 12, 2019 /PRNewswire/ -- Today, Healthy.io, the global leader in turning the smartphone camera into a clinical-grade medical device, announced it has

INCLINE VILLAGE, Nev., Sept. 11, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced that the Supreme Court of New York, County of New York, Commercial Division, issued its decision today in PDL's previously disclosed litigation related to defaults by Wellstat Di

BURLINGAME, Calif., Sept. 11, 2019 /PRNewswire/ -- Color open-sources a playbook that provides the underlying framework for its Population Genomics Platform. The playbook is available to organizations working to build and scale population genomics programs. By open-sourcing this playbook, Color is supporting global efforts to make genetics and precision health programs accessible, convenient, and c

STOCKHOLM, Sept. 11, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that clinical trial data were presented at the Society of Hematologic Oncology (SOHO) 2019 Annual Meeting in Houston, TX, USA. In an oral presentation, data from the pivotal Phase 2 HORIZON clinical trial were presented as part of the meeting's multip

WASHINGTON, Sept. 11, 2019 /PRNewswire/ -- President Trump's announcement that the government will remove flavored e-cigarettes from the market is a necessary and long-overdue step to address the epidemic of youth e-cigarette use in the United States, but it must be comprehensive, immediate and long-lasting. This is a public health crisis

NASHVILLE, Tenn., Sept. 11, 2019 /PRNewswire/ -- SmileDirectClub, Inc., the industry pioneer and first direct-to-consumer medtech platform for transforming smiles, today announced the pricing of its initial public offering of 58,537,000 shares of its Class A common stock at a price to the public of $23.00 per share. SmileDirectClub has

ALHAMBRA, Calif., Sept. 11, 2019 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, today announced that it has closed a new credit facility. The new aggregate $290 million credit facility consists of a $190 million sen